Vestibular Therapy in Alzheimer's Disease
NCT03799991 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-01-12
Summary
Nearly 2 out of 3 patients with Alzheimer's disease (AD) experience problems with balance and mobility, which places such patients at increased risk of falling. The vestibular (inner ear balance) system plays an important role in balance stability, and vestibular therapy (VT) is well-known to improve balance function in healthy older adults. In this study, the investigators will conduct a first-in-kind randomized clinical trial to evaluate whether vestibular therapy improves reduces falls in patients with AD, in whom this treatment has never been studied.
Conditions
- Vestibular Diseases
- Vestibular Disorder
- Alzheimer Disease
Interventions
- BEHAVIORAL
-
Vestibular physical therapy
Vestibular therapy is a set of exercises delivered by a physical therapist involving head movements. The therapy is delivered over a course of 8 weeks.
- BEHAVIORAL
-
Active control
Strength and flexibility exercises that do not involve head movements.
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH - lead OTHER
Principal Investigators
-
Yuri Agrawal, MD · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-22
- Primary Completion
- 2027-08-26
- Completion
- 2027-08-26
Countries
- United States
Study Locations
More Related Trials
-
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
NCT02585934 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease
NCT01584440 ·Status: COMPLETED ·Phase: PHASE2
-
VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease
NCT06874621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multicenter Evaluation of Memory Remediation After TBI With Donepezil
NCT02255799 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
NCT06651567 ·Status: RECRUITING ·Phase: PHASE2
-
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
NCT00097916 ·Status: COMPLETED ·Phase: PHASE3
-
Memory Impairment Study (Mild Cognitive Impairment Study)
NCT00000173 ·Status: COMPLETED ·Phase: PHASE3
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease
NCT02817906 ·Status: TERMINATED ·Phase: PHASE3
-
Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease
NCT02222181 ·Status: COMPLETED ·Phase: NA
-
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
NCT06647498 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Network-Level Mechanisms for Preclinical Alzheimer's Disease Development
NCT03461861 ·Status: COMPLETED ·Phase: PHASE2
-
Donepezil Effect on Visual Attention and Training
NCT01738295 ·Status: COMPLETED ·Phase: NA
-
Addressing Dementia Via Agitation-Centered Evaluation
NCT03226522 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study on Early Brain Injury Mechanism and Comprehensive Intervention of VCI
NCT04999813 ·Status: UNKNOWN ·Phase: NA
-
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
NCT00315900 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
NCT02079909 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
NCT02910102 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Delirium in the Elderly With Donepezil: a Double-blind, Randomized, Placebo-controlled Clinical Trial
NCT01633593 ·Status: TERMINATED ·Phase: PHASE4
-
The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease
NCT00006187 ·Status: TERMINATED ·Phase: PHASE3
-
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
NCT03748303 ·Status: TERMINATED ·Phase: PHASE1
-
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163 ·Status: COMPLETED ·Phase: PHASE4
-
The Nicotinic Cholinergic System and Cognitive Aging
NCT03408574 ·Status: COMPLETED ·Phase: PHASE1